News
EVerMed Inc. received investment from Summit Pharmaceuticals International Corporation (SPI)
October 15, 2024 EVerMed Inc. received investment from SPI as the 2nd closing of its seed round. With this capital increase, EVerMed will accelerate the development of its pipeline. SPI is a provider of high-quality integrated products and services to the Read more…